Trials / Completed
CompletedNCT06047275
HCV Microfluidic Diagnostics
Development of Point-of-care and Wearable Sensors for Hepatitis C Diagnostics
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 38 (actual)
- Sponsor
- University of Hull · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Hepatitis C diagnostic devices have been developed at the University of Hull to detect and quantify the Hepatitis C virus in patients' plasma and serum samples. This study aims to test the new point-of-care devices that are designed to be low cost and user-friendly. Excess, stored, HCV patients' plasma, serum and blood samples will be supplied by the Virology laboratory (Hull University Teaching Hospital's Trust; HUTH). These samples were taken and analysed as part of patients' clinical monitoring, and are stored prior to disposal in the Virology laboratory. The proposed study will use the samples in a fully anonymised manner.
Conditions
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2024-03-31
- Completion
- 2024-03-31
- First posted
- 2023-09-21
- Last updated
- 2024-07-10
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT06047275. Inclusion in this directory is not an endorsement.